ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
섬유아세포 시장 규모는 향후 수년간 강력한 성장이 예상될 예정입니다.
이러한 미래의 성장은 맞춤형 세포 치료에 대한 강조가 높아지고, 미용 및 노화 방지 치료에 대한 수요가 증가하며, 줄기 세포 및 재생 의학 접근법이 널리 수용되고, 세포 기반 연구에 대한 재정 지원이 확대되고, 3D 바이오 프린팅 및 오가노이드(organ-on-chip) 혁신이 점점 더 많이 채택됨에 따라 뒷받침될 것입니다. 예측 기간에 예상되는 주요 동향으로는 3D 세포 배양 기술의 발전, 조직 복구 및 재생 의학에서의 새로운 용도, 무혈청 및 정의된 배양 배지의 발전, 세포 연구에 인공 지능의 통합, 섬유아세포를 변형하기 위한 유전자 편집 기술의 개선 등이 있습니다.
다양한 피부 질환의 유병률이 증가함에 따라 향후 몇 년 동안 섬유아세포 시장이 성장할 것으로 예상됩니다. 피부 질환은 피부에 영향을 미치는 상태 또는 질병으로, 발진, 가려움, 염증, 발적, 건조 또는 병변과 같은 증상을 유발합니다. 피부 질환의 증가는 주로 피부 장벽을 손상시키고 염증을 유발하며 피부 질환에 대한 취약성을 높이는 환경 오염 물질에 대한 노출이 증가하기 때문입니다. 섬유아세포는 콜라겐 및 기타 세포외 기질 성분의 생산을 통해 조직 복구와 재생을 돕는 방식으로 피부 질환 치료에 기여합니다. 예를 들어, 2025년 2월 호주 정부 기관인 Cancer Australia는 2023년에 진단된 피부 흑색종 신규 사례가 18,257건이라고 보고했습니다. 따라서 피부 질환의 증가하는 유병률은 섬유아세포 시장 성장을 촉진하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 19 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 섬유아세포 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 섬유아세포 시장 : 성장률 분석
세계의 섬유아세포 시장 실적 : 규모와 성장(2019-2024년)
세계의 섬유아세포 시장 예측 : 규모와 성장(2024-2029년, 2034년)
세계의 섬유아세포 : 전체 시장 규모(TAM)
제6장 시장 세분화
세계의 섬유아세포 시장 : 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
조직 특이적 섬유아세포
질환 특이적 섬유아세포
무혈청 섬유아세포 배양 배지
세계의 섬유아세포 시장 : 용도별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
성인
신생아
세계의 섬유아세포 시장 : 최종 사용자별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
병원
클리닉
연구 및 학술기관
기타 최종 사용자
세계의 섬유아세포 시장 : 조직 특이적 섬유아세포 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
진피 섬유아세포
폐섬유아세포
심장 섬유아세포
잇몸 섬유아세포
각막 섬유아세포
유선섬유아세포
장내 섬유아세포
포피 섬유아세포
세계의 섬유아세포 시장 : 질환 특이적 섬유아세포 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
암 관련 섬유아세포(CAF)
특발성 폐 섬유증 섬유 아세포
피부경화증 섬유아세포
당뇨병 상처 섬유아세포
류마티스 관절염 섬유아세포
켈로이드 섬유아세포
건선 섬유아세포
세계의 섬유아세포 시장 : 무혈청 섬유아세포 배양 배지 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
진피 섬유아세포 배지
폐 섬유아세포 배지
심장 섬유아세포 배지
암 관련 섬유아세포 배지
인간 치은 섬유아세포 배지
섬유아세포 증식 배지(이종 물질 미사용)
섬유아세포 증식을 위한 맞춤 배지 또는 규정 배지
제7장 지역별, 국가별 분석
세계의 섬유아세포 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
세계의 섬유아세포 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
섬유아세포 시장 : 경쟁 구도
섬유아세포 시장 : 기업 프로파일
Thermo Fisher Scientific Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Lonza Group AG : 개요, 제품 및 서비스, 전략 및 재무 분석
Sigma-Aldrich Corporation : 개요, 제품 및 서비스, 전략 및 재무 분석
Bio-Techne Corporation : 개요, 제품 및 서비스, 전략 및 재무 분석
STEMCELL Technologies Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
American Type Culture Collection
Creative Bioarray
PromoCell GmbH
Coriell Institute for Medical Research
REPROCELL Inc.
Axol Bioscience Ltd.
ScienCell Research Laboratories Inc.
Cell Applications Inc.
ZenBio Inc.
Cell Biologics Inc.
Lifeline Cell Technology
Celprogen Inc.
AMS Biotechnology(Europe) Ltd.
Neuromics Inc.
Evercyte GmbH
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
섬유아세포 시장(2029년) : 새로운 기회를 제공하는 국가
섬유아세포 시장(2029년) : 새로운 기회를 제공하는 부문
섬유아세포 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
HBR
영문 목차
영문목차
Fibroblast cells are specialized cells located in connective tissues, playing a vital role in wound healing and tissue regeneration. These cells are responsible for producing and sustaining the extracellular matrix, which includes collagen and various structural proteins. Their primary function is to aid in tissue support and repair by synthesizing collagen and other fibers. Fibroblasts are crucial for preserving the integrity and strength of the skin and respond actively to injuries by facilitating the healing and regenerative processes.
Fibroblast cells are categorized into tissue-specific fibroblasts, disease-specific fibroblasts, and serum-free fibroblast culture medium. Tissue-specific fibroblasts are derived from healthy organs and maintain distinct characteristics of their origin, making them valuable for tissue reconstruction and accurate disease modeling. These cells are applicable across various age groups, including adults and neonates, and are used by end-users such as hospitals, clinics, academic and research institutions, and others.
The fibroblast cells market research report is one of a series of new reports from The Business Research Company that provides fibroblast cells market statistics, including the fibroblast cells industry global market size, regional shares, competitors with the fibroblast cells market share, detailed fibroblast cells market segments, market trends, opportunities, and any further data you may need to thrive in the fibroblast cells industry. This fibroblast cells market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The fibroblast cells market size has grown strongly in recent years. It will grow from $0.69 billion in 2024 to $0.76 billion in 2025 at a compound annual growth rate (CAGR) of 9.8%.
This growth during the historic period was driven by the expanding use of cosmetic and anti-aging solutions, increased implementation of 3D cell culture systems, enhanced government investment in cell therapy research, a heightened awareness of personalized medicine, and broader usage in drug development and toxicity screening.
The fibroblast cells market size is expected to see strong growth in the next few years. It will grow to $1.08 billion in 2029 at a compound annual growth rate (CAGR) of 9.5%.
This future growth will be supported by a heightened emphasis on personalized cellular therapies, increased demand for aesthetic and anti-aging treatments, wider acceptance of stem cell and regenerative medicine approaches, greater financial support for cell-based studies, and growing adoption of 3D bioprinting and organ-on-chip innovations. Key trends anticipated in the forecast period include progress in 3D cell culture technologies, novel uses in tissue repair and regenerative medicine, advancements in serum-free and defined culture media, the incorporation of artificial intelligence in cellular studies, and improved gene editing techniques for modifying fibroblasts.
The rising prevalence of various skin disorders is anticipated to drive the growth of the fibroblast cells market in the coming years. Skin disorders are conditions or diseases affecting the skin, resulting in symptoms such as rashes, itching, inflammation, redness, dryness, or lesions. This increase in skin disorders is largely attributed to growing exposure to environmental pollutants, which harm the skin barrier and lead to inflammation and greater susceptibility to skin conditions. Fibroblast cells contribute to the treatment of skin disorders by aiding tissue repair and regeneration through the production of collagen and other extracellular matrix components, which help restore the skin's strength and elasticity. For example, in February 2025, Cancer Australia, a government agency, reported 18,257 new cases of melanoma of the skin diagnosed in 2023. Consequently, the increasing prevalence of skin disorders is fueling the growth of the fibroblast cells market.
Key companies in the fibroblast cells market are focusing on developing advanced technologies, such as macrophage phenotype identification, to improve understanding of cell interactions and enhance the efficacy of fibroblast-based therapies. Macrophage phenotype identification involves distinguishing between macrophage types, primarily M1 and M2, based on their functional characteristics and molecular markers. For instance, in December 2024, Creative Biolabs, a biotechnology company based in the US, introduced Fibroblast Growth Factor 2. This product includes two versions-Fibroblast Growth Factor 2 and Fibroblast Growth Factor 2 STAB-designed to promote the proliferation of human mesenchymal stem cells (MSCs) and normal human dermal fibroblasts (NHDFs), thereby supporting advancements in stem cell and regenerative medicine research.
In October 2024, Fibrobiologics Inc., a US-based developer of fibroblast cell-based therapies for chronic diseases, entered into a partnership with Charles River Laboratories to advance regenerative therapies through scientific collaboration. This partnership aims to expedite the development and clinical readiness of fibroblast cell-based treatments, including CYWC628, by leveraging Charles River's expertise in manufacturing and testing to support upcoming clinical trials targeting chronic conditions such as diabetic foot ulcers. Charles River Laboratories is a US-based organization that offers preclinical and clinical laboratory services, along with gene and cell therapy support.
Major players in the fibroblast cells market are Thermo Fisher Scientific Inc., Lonza Group AG, Sigma-Aldrich Corporation, Bio-Techne Corporation, STEMCELL Technologies Inc., American Type Culture Collection, Creative Bioarray, PromoCell GmbH, Coriell Institute for Medical Research, REPROCELL Inc., Axol Bioscience Ltd., ScienCell Research Laboratories Inc., Cell Applications Inc., ZenBio Inc., Cell Biologics Inc., Lifeline Cell Technology, Celprogen Inc., AMS Biotechnology (Europe) Ltd., Neuromics Inc., Evercyte GmbH, and FUJIFILM Irvine Scientific Inc.
North America was the largest region in the fibroblast cells market in 2024. The regions covered in fibroblast cells report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the fibroblast cells market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The fibroblast cells market consists of sales of normal human fibroblasts (NHF), immortalized fibroblast cell lines, cryopreserved fibroblasts, fibroblast growth media, fibroblast differentiation kits, and 3D fibroblast culture systems. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Fibroblast Cells Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on fibroblast cells market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for fibroblast cells ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The fibroblast cells market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Type: Tissue-Specific Fibroblasts; Disease-Specific Fibroblasts; Serum-Free Fibroblast Culture Medium
2) By Application: Adults; Neonatal
3) By End-Users: Hospitals; Clinics; Research And Academic Institutes; Other End-Users
3) By Serum-Free Fibroblast Culture Medium: Dermal Fibroblast Medium; Lung Fibroblast Medium; Cardiac Fibroblast Medium; Cancer-Associated Fibroblast Medium; Human Gingival Fibroblast Medium; Fibroblast Growth Medium (Xeno-Free); Custom Or Defined Media For Fibroblast Expansion
Companies Mentioned: Thermo Fisher Scientific Inc.; Lonza Group AG; Sigma-Aldrich Corporation; Bio-Techne Corporation; STEMCELL Technologies Inc.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Fibroblast Cells Market Characteristics
3. Fibroblast Cells Market Trends And Strategies
4. Fibroblast Cells Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Fibroblast Cells Growth Analysis And Strategic Analysis Framework
5.1. Global Fibroblast Cells PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Fibroblast Cells Market Growth Rate Analysis
5.4. Global Fibroblast Cells Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Fibroblast Cells Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Fibroblast Cells Total Addressable Market (TAM)
6. Fibroblast Cells Market Segmentation
6.1. Global Fibroblast Cells Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Tissue-Specific Fibroblasts
Disease-Specific Fibroblasts
Serum-Free Fibroblast Culture Medium
6.2. Global Fibroblast Cells Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Adults
Neonatal
6.3. Global Fibroblast Cells Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Clinics
Research And Academic Institutes
Other End-Users
6.4. Global Fibroblast Cells Market, Sub-Segmentation Of Tissue-Specific Fibroblasts, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Dermal Fibroblasts
Lung Fibroblasts
Cardiac Fibroblasts
Gingival Fibroblasts
Corneal Fibroblasts
Mammary Fibroblasts
Intestinal Fibroblasts
Foreskin Fibroblasts
6.5. Global Fibroblast Cells Market, Sub-Segmentation Of Disease-Specific Fibroblasts, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cancer-Associated Fibroblasts (CAFs)
Idiopathic Pulmonary Fibrosis Fibroblasts
Scleroderma Fibroblasts
Diabetic Wound Fibroblasts
Rheumatoid Arthritis Fibroblasts
Keloid Fibroblasts
Psoriatic Fibroblasts
6.6. Global Fibroblast Cells Market, Sub-Segmentation Of Serum-Free Fibroblast Culture Medium, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Dermal Fibroblast Medium
Lung Fibroblast Medium
Cardiac Fibroblast Medium
Cancer-Associated Fibroblast Medium
Human Gingival Fibroblast Medium
Fibroblast Growth Medium (Xeno-Free)
Custom Or Defined Media For Fibroblast Expansion
7. Fibroblast Cells Market Regional And Country Analysis
7.1. Global Fibroblast Cells Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Fibroblast Cells Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
